Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib Progression

Clinical trial NCT07199010 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07199010
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Non-small Lung Cancer

Start date: 2025-10-01
Primary completion: 2027-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.